Tag Archives: J.P. Morgan

J.P. Morgan: Suits Take San Francisco

The perennial fat got chewed during the first two days at J.P. Morgan’s annual healthcare conference – buy back stock or raise dividends? – and the usual suspects lurked, but newcomers like Walgreens and not-so-pharma companies like Life Technologies packed the presentation halls and corridors, demonstrating investor and general interest in new ideas, products and […]
Posted in Biotech, Deals, Events, Global, healthcare, leadership, pricing, R&D, Regulatory, Strategy, Technology | Tagged | Leave a comment

JP Morgan Healthcare Conference Marked by Uncertainty

2012 J.P. Morgan Healthcare Conference Marked by Uncertainty Audrey S. Erbes, Principal, Erbes & Associates, outlines the highlights of this week’s event in San Francisco. One of the few positive notes struck in this week’s 30th Annual J.P. Morgan Healthcare Conference (held in San Francisco) was the announcement by Kevin Willsey, J.P. Morgan’s co-head of […]
Posted in Guest Blog, healthcare, R&D, Strategy | Also tagged , , , | 2 Comments
  • Categories

  • Meta